A comparison of anti-anginal effects of nicorandil (SG-75) with isosorbide mononitrate (ISMN) in patients with stable angina pectoris:A multicenter, randomized, double-blind trial in China.
Phase 3
- Conditions
- Stable angina pectoris
- Registration Number
- JPRN-jRCT2080220014
- Lead Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1)males or females older than 18 year-old
2)a history of stable angina pectoris for at least one month ( according to the Guideline for Diagnosis of Angina Pectoris in China)
3)chest pain being relievable by short-acting nitrates
4)willing to provid written informed consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy: change in time to 1mm ST-segment depression in exercise tolerance test Safety: adverse drug reaction and adverse events
- Secondary Outcome Measures
Name Time Method